Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Obesity

Free Subscription 03.11.2025 1 Diabetes 2 Eur J Endocrinol 1 Lancet 1 Obes Surg 8 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Diabetes

1. QIAO L, Lu C, Saget S, Shao J, et al
   Maternal Obesity Programs Glucose Intolerance in Pregnant Female Offspring.
   Diabetes. 2025 Oct 27:db250603. doi: 10.2337/db25-0603.
   PubMed         Abstract available
   
   

   
   Eur J Endocrinol

2. LUQUE-RAMIREZ M, Martinez-Garcia MA, Insenser M, Quintero-Tobar A, et al
   Lipoprotein subclasses compensate the classic atherogenic lipid profile of women with polycystic ovary syndrome, but common antiandrogenic treatments worsen their lipidome.
   Eur J Endocrinol. 2025;193:595-605.
   PubMed         Abstract available
   
   
3. VAN EENIGE R, Sanchez-Lopez E, Hoekstra AT, Ying Z, et al
   Inhibition of endocannabinoid synthesis enzymes DAGL and NAPE-PLD transiently lowers body weight and alters glucose homeostasis during a high-fat diet challenge in mice.
   Eur J Endocrinol. 2025;193:618-626.
   PubMed         Abstract available
   
   

   
   Lancet

4. DEANFIELD J, Lincoff AM, Kahn SE, Emerson SS, et al
   Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
   Lancet. 2025 Oct 22:S0140-6736(25)01375-3. doi: 10.1016/S0140-6736(25)01375.
   PubMed         Abstract available
   
   

   
   Obes Surg

5. KERMANSARAVI M, Cohen RV
   Clinical Obesity Through the Lens of Context-Aware Large Language Models.
   Obes Surg. 2025 Oct 29. doi: 10.1007/s11695-025-08341.
   PubMed         Abstract available
   
   

   
   PLoS One

6. FOLLING IS, Reigstad SL, Hyldmo AA, Helvik AS, et al
   Patient experiences with liraglutide for obesity and binge eating disorder-A qualitative study.
   PLoS One. 2025;20:e0335806.
   PubMed         Abstract available
   
   
7. WAKASA H, Sunohara S, Kimura T, Ichikawa T, et al
   Association between obesity and mortality from hematological malignancies among Japanese adults: The Japan Collaborative Cohort study.
   PLoS One. 2025;20:e0335750.
   PubMed         Abstract available
   
   
8. RAHMAN SA, Kabir MH, Rahman SS, Kamruzzaman M, et al
   Correction: The validity of mid-upper arm circumference as an indicator of underweight, overweight and obesity adults in Bangladesh.
   PLoS One. 2025;20:e0335763.
   PubMed         Abstract available
   
   
9. NORLIN J, Dermit M, Sidiropoulos N, Galsgaard ED, et al
   The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASH.
   PLoS One. 2025;20:e0331665.
   PubMed         Abstract available
   
   
10. MAKO M, Rafiqi N, Noori A, Rahimi BA, et al
    The prevalence of overweight and obesity and the assessment of associated risk factors among school-aged adolescents in Kandahar City, Afghanistan.
    PLoS One. 2025;20:e0335359.
    PubMed         Abstract available
    
    
11. ELLOUMI M, Makni E, Pacholek M, Ben Brahim M, et al
    Key body size/shape predictors of physical fitness in Saudi College-aged males: Role of the body roundness index.
    PLoS One. 2025;20:e0333942.
    PubMed         Abstract available
    
    
12. MA EJ, Roberts AM, Chou P, Katz A, et al
    Chronic companions: An updated national cross-sectional study of metabolic syndrome comorbidities in outpatient visits for hidradenitis suppurativa.
    PLoS One. 2025;20:e0333010.
    PubMed         Abstract available
    
    
13. VIEIRA TA, Siqueira JS, Nakandakare-Maia ET, Grandini NA, et al
    Anti-inflammatory effect of bergamot leaves extract attenuates cardiac remodeling in obese rats by regulating the protein expression of the collagen/metalloproteinase axis.
    PLoS One. 2025;20:e0334015.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.